LBT Innovations receives $4M funding from the South Australian Government supporting jobs and innovation
LBT Innovations is pleased to announce we have received $4M in funding from the South Australian Government
- 29 Jan 2018 -- Quarterly Activities & Cash Flow Report - Appendix 4C
- 8.1.17 -- LBT Presentation JP Morgan Biotech Showcase
LBT Innovations: expansion and development in artificial intelligence platforms
Published quarterly, The ABE provides an in depth view of business and economic development issues taking place across the country. Featuring interviews with top executives, government policy makers and prominent industry bodies, The ABE examines the news beyond the headlines to uncover the drivers of local, state, and national affairs.
Company OverviewOver the past decade, LBT Innovations has emerged as a groundbreaking designer of advanced automated solutions for the preparation and analysis of microbiology culture specimens, with significant benefi...
MicroStreakIn its first five years of global sales, LBT’s MicroStreak technology captured the largest share of the international market for automated culture-plate streaking and inoculation. Originally sold by bi...
APASThe Automated Plate Assessment System, or APAS, is a platform technology for the automation of culture-plate screening and interpretation. While LBT’s first product, PREVI Isola, automates the inoculati...